MorphoSys and Xencor Complete Enrollment in MOR208 (Xmab5574) Phase 1 Trial in CLL - Reuters
Posted by admin / Under TecDAX
MorphoSys and Xencor Complete Enrollment in MOR208 (Xmab5574) Phase 1 Trial in CLL Reuters Study Data Expected in Q4 2012 MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) and US-based Xencor, Inc. today announced the successful completion of patient enrollment in the phase 1 clinical trial evaluating MOR208. |
Published on Tuesday 22nd of May 2012 09:23:58 AM
MorphoSys to Present MOR208 Preclinical Combination Therapy Data at ASCO Meeting - Reuters
Posted by admin / Under TecDAX
MorphoSys to Present MOR208 Preclinical Combination Therapy Data at ASCO Meeting Reuters Synergistic Effects Seen with Four Approved Treatment Options Including Rituximab and Ofatumumab MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced promising pre-clinical data on its proprietary drug candidate MOR208. |
Published on Tuesday 22nd of May 2012 09:23:58 AM
Evotec Becomes the First Contract Research Facility in Europe to Offer ... - MarketWatch (press release)
Posted by admin / Under TecDAX
Evotec Becomes the First Contract Research Facility in Europe to Offer ... MarketWatch (press release) HAMBURG, Germany, May 16, 2012 (GlobeNewswire via COMTEX) -- Evotec AG (frankfurt:EVT) (TecDAX) is proud to announce the addition of Agilent Technologies' RapidFire Mass Spectrometry analysis capabilities to their High Throughput Screening facilities ... |
Published on Tuesday 22nd of May 2012 09:23:58 AM
Software AG Debuts B2B.com Series: Supercharging Your Supply Chain - SYS-CON Media (press release)
Posted by admin / Under TecDAX
Software AG Debuts B2B.com Series: Supercharging Your Supply Chain SYS-CON Media (press release) The company is headquartered in Germany and listed on the Frankfurt Stock Exchange (TecDAX, ISIN DE 0003304002 / SOW). Syndicated stories and blog feeds, all rights reserved by the author. By Pat Romanski Did you read today's front page stories ... |
Published on Tuesday 22nd of May 2012 09:23:58 AM
Software AG Introduces iKnow -- an Order Visibility Solution -- which Improves ... - MarketWatch (press release)
Posted by admin / Under TecDAX
Software AG Introduces iKnow -- an Order Visibility Solution -- which Improves ... MarketWatch (press release) Our comprehensive software and services solutions allow companies to continuously achieve their business results faster. The company is headquartered in Germany and listed on the Frankfurt Stock Exchange (TecDAX, ISIN DE 0003304002 / SOW). |
Published on Tuesday 22nd of May 2012 09:23:58 AM
Evotec Reports Continued Strong Revenue Growth in Q1 2012 - MarketWatch (press release)
Posted by admin / Under TecDAX
Evotec Reports Continued Strong Revenue Growth in Q1 2012 MarketWatch (press release) HAMBURG, Germany, May 10, 2012 (GLOBE NEWSWIRE) -- Evotec AG (frankfurt:EVT) (TecDAX) today reported financial results and corporate updates for the first quarter of 2012. Evotec's operational performance for the first quarter of 2012 reflected the ... |
Published on Tuesday 22nd of May 2012 09:23:58 AM
MorphoSys to Present at Three Investor Conferences in May - Reuters
Posted by admin / Under TecDAX
MorphoSys to Present at Three Investor Conferences in May Reuters MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its management will present at three international investor conferences in May. Deutsche Bank 37 th Annual Healthcare Conference Date: May 07, 2012, 10:00 am EDT (04:00 pm ... |
Published on Tuesday 22nd of May 2012 09:23:58 AM
Evotec AG and 4-Antibody AG Form Strategic Collaboration to Innovate Antibody ... - MarketWatch (press release)
Posted by admin / Under TecDAX
Evotec AG and 4-Antibody AG Form Strategic Collaboration to Innovate Antibody ... MarketWatch (press release) HAMBURG, Germany and BASEL, Switzerland, May 9, 2012 (GLOBE NEWSWIRE) -- Evotec AG (frankfurt:EVT) (TecDAX) and 4-Antibody AG today announced the signing of a strategic collaboration agreement under which Evotec will offer a fully integrated antibody ... |
Published on Tuesday 22nd of May 2012 09:23:58 AM
MorphoSys to Host Q1 2012 Conference Call on May 04, 2012 - Reuters
Posted by admin / Under TecDAX
MorphoSys to Host Q1 2012 Conference Call on May 04, 2012 Reuters MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) will publish its first three months' 2012 results on May 04, 2012 at 7:00 am CEST. At 2:00 pm CEST (1:00 pm BST, 8:00 am EDT), the Management Board of MorphoSys AG will host a public conference ... |
Published on Tuesday 22nd of May 2012 09:23:58 AM
MorphoSys AG Reports Results for the First Quarter of 2012 - Reuters
Posted by admin / Under TecDAX
MorphoSys AG Reports Results for the First Quarter of 2012 Reuters MorphoSys AG (FSE: MOR; Prime Standard Segment; TecDAX) today announced its financial results for the three months ending March 31, 2012 according to International Financial Reporting Standards (IFRS). Group revenues decreased to EUR 16.1 million (Q1 ... |
Published on Tuesday 22nd of May 2012 09:23:58 AM
Share this!